BioCardia Depreciation & Amortization Growth & History (BCDA)

BioCardia's depreciation and amortization was $24,000 for fiscal 2025.

View full BioCardia company overview

BioCardia annual depreciation and amortization history

BioCardia annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$24,000−$43,000−64.18%
20242024-12-31$67,000−$17,000−20.24%
20232023-12-31$84,000$2,000+2.44%
20222022-12-31$82,000$22,000+36.67%
20212021-12-31$60,000−$8,000−11.76%
20202020-12-31$68,000−$43,000−38.74%
20192019-12-31$111,000$23,000+26.14%
20182018-12-31$88,000$10,000+12.82%
20172017-12-31$78,000$39,000+100.00%
20162016-12-31$39,000−$8,000−17.02%
20152015-12-31$47,000
20112011-12-31$0−$967,000
20102010-12-31$967,000

BioCardia depreciation and amortization trends

Over the last five fiscal years, BioCardia's depreciation and amortization decreased from $68,000 to $24,000, a change of −$44,000. The latest reported quarter, Q2 2026, shows $3,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioCardia source filings ↗

Community posts

It’s quiet here.

No posts about BCDA yet. Start the conversation.

Write the first post